Vol 12, No 4 (April 28, 2023): Translational Cancer Research

Editorial Commentary

Sequential therapy with induction chemotherapy and chemoradiotherapy in pre-irradiated recurrent head and neck squamous cell carcinoma incorporating nab-paclitaxel—a commentary of the phase I trial of AFHX followed by concomitant FHX scheme
Javier Martinez-Trufero, Ana Comin Orce, Pablo Gomez Mugarza, Susana Barriendos Sanz, Eugenia Ortega Izquierdo
Translational Cancer Research  
2023;
12
(4)
:692-696
.
Induction therapy in recurrent head and neck squamous cell carcinoma: is it time to consider response as a determinant of treatment selection?
Jason Tasoulas, Siddharth Sheth
Translational Cancer Research  
2023;
12
(4)
:697-700
.
Combining immunotherapy and radiotherapy in hepatocellular carcinoma: the importance of irradiated tumor burden and the possible role of a low dose radiotherapy induction strategy
Clemens Grassberger, Gentry King, Smith Apisarnthanarax
Translational Cancer Research  
2023;
12
(4)
:701-704
.
PD-L1 expression on tumor cells as a potential predictive biomarker for patients with unresectable stage III non-small cell lung cancer treated with chemoradiotherapy followed by durvalumab
Lukas Käsmann, Alexander Nieto, Julian Taugner, Farkhad Manapov
Translational Cancer Research  
2023;
12
(4)
:705-708
.
In silico trials of combination immuno-radiation for unresectable hepatocellular carcinoma
Mishal Mendiratta-Lala, Issam El Naqa, Dawn Owen
Translational Cancer Research  
2023;
12
(4)
:709-712
.
Increased abscopal responses after radiation therapy for oligoprogressive patients receiving immune checkpoint inhibitors?
Jérôme Doyen, Antonin Levy
Translational Cancer Research  
2023;
12
(4)
:713-716
.

Original Article

An integrated bioinformatics analysis of the S100 in head and neck squamous cell carcinoma
Guo Bai, Shijing Yue, Yuanhe You, Jiong Zhao, Zhuowei Tian, Yanan Wang, Zhiyuan Zhang, Chi Yang
Translational Cancer Research  
2023;
12
(4)
:717-731
.
Efficacy and safety of methylphenidate and ginseng in cancer-related fatigue: a network meta-analysis of randomized controlled trials
Huijing Li, Kaimeng Che, Zheng Zhi, Wenzhong Xu, Jing Huang, Xueqi Wang, Xi Liang, Tianhe Zhao, Jingnan Hu, Tianwen Hou, Shijiang Sun, Jianming He
Translational Cancer Research  
2023;
12
(4)
:732-742
.
Ferula sinkiangensis against gastric cancer: a network pharmacology, molecular docking and cell experiment study
Dexi Wang, Yun Sun, Qiaoyun Liu, Chenyu Ye, Shengjun Zhao, Haiying Zhang
Translational Cancer Research  
2023;
12
(4)
:743-764
.
CT-based three-dimensional invasiveness analysis of adenocarcinoma presenting as pure ground-glass nodules
Jieun Oh, Zhe Piao, Hyun Jin Cho, Yooyoung Chong, Song Soo Kim, Jin Hwan Kim, Min-Woong Kang
Translational Cancer Research  
2023;
12
(4)
:765-773
.
Bioinformatics identification of prognostic genes and potential interaction analysis in renal cell carcinoma
Yimin Yuan, Jingzi Wang, Liqu Huang, Yunfei Guo
Translational Cancer Research  
2023;
12
(4)
:774-783
.
The influence of antibody CD166 on the treatment of tumor and the immunological mechanism in mice bearing oral squamous cell carcinoma
Binbin Yu, Rui Li, Xueqin Zhu, Zhengbing Chi
Translational Cancer Research  
2023;
12
(4)
:784-792
.
Nomogram for predicting preoperative axillary lymph node status in male breast carcinoma: a SEER population-based study
Wenxin Chen, Hebing Wang, Binglin Yang, Maoquan Zhang, Jicheng Chen
Translational Cancer Research  
2023;
12
(4)
:793-803
.
Establishment and validation of nomograms for predicting survival of lung invasive adenocarcinoma based on the level of pathological differentiation: a SEER cohort-based analysis
Xiaokun Wang, Yongrui Xu, Jinyu Xu, Yundi Chen, Chenghu Song, Guanyu Jiang, Ruo Chen, Wenjun Mao, Mingfeng Zheng, Yuan Wan
Translational Cancer Research  
2023;
12
(4)
:804-827
.
Methyl vanillate for inhibiting the proliferation, migration, and epithelial-mesenchymal transition of ovarian cancer cells via the ZEB2/Snail signaling pathway
Ling Wang, Yali Miao, Jirui Wen, Juan Cheng, Qiao Wen, Zhiwei Zhao, Jiang Wu
Translational Cancer Research  
2023;
12
(4)
:828-836
.
Detection of EGFR mutations in early-stage lung adenocarcinoma by machine learning-based radiomics
Kenshiro Omura, Yu Murakami, Kohei Hashimoto, Hikaru Takahashi, Ryoko Suzuki, Yasuo Yoshioka, Masahiko Oguchi, Junji Ichinose, Yosuke Matsuura, Masayuki Nakao, Sakae Okumura, Mingyon Mun
Translational Cancer Research  
2023;
12
(4)
:837-847
.
The 100 most cited papers in nasopharyngeal carcinoma between 2000 and 2019: a bibliometric study
Cong-Yan Xing, Min-Qiang Lin, Wen-Ting Luo, Long-Fei Chen, San-Gang Wu, Yi-Jia Cai
Translational Cancer Research  
2023;
12
(4)
:848-858
.
High expression of RTN4IP1 predicts adverse prognosis for patients with breast cancer
Xiu Wang, Xinyu Li, Wenying Jiang
Translational Cancer Research  
2023;
12
(4)
:859-872
.
Multicenter, single-arm phase II study of modified carboplatin/nab-paclitaxel in untreated performance status 2 patients with advanced non-small cell lung cancer: TORG1426
Yasuko Ichikawa, Nobuhiko Seki, Takeshi Honda, Makoto Sakugawa, Shinobu Hosokawa, Akihiro Bessho, Yoko Agemi, Tsuneo Shimokawa, Sakiko Otani, Yoshiro Nakahara, Katsuhiko Naoki, Makiko Yomota, Yukio Hosomi, Yuichi Takiguchi, Takaaki Tokito, Shuji Ando, Hiroaki Okamoto
Translational Cancer Research  
2023;
12
(4)
:873-886
.
Identification and experimental verification of an anoikis and immune related signature in prognosis for lung adenocarcinoma
Jia-Le Zhang, Yan-Xin Dong, Shou-Yin Di, Bo-Shi Fan, Tai-Qian Gong
Translational Cancer Research  
2023;
12
(4)
:887-903
.
The efficacy and safety of apatinib in patients with heavily pretreated end-stage cancer: a retrospective study
Zhenyu Li, Xiaoshu Zhou, Shuai Wang, Liangliang Shi, Rui Meng, Xiaofang Dai, Yi Liu, Xueke Lin, Yong Xiao, Gang Peng
Translational Cancer Research  
2023;
12
(4)
:904-912
.
High expression of miR-107 and miR-17 predicts poor prognosis and guides treatment selection in acute myeloid leukemia
Yue Liu, Yang Cao, Xiaojun Yang, Huijuan Chen, Haonan Yang, Yan Liu, Weiying Gu
Translational Cancer Research  
2023;
12
(4)
:913-927
.
Comparing the cost-effectiveness of sintilimab + pemetrexed plus platinum and pemetrexed plus platinum alone as a first-line therapy for Chinese patients with nonsquamous non-small cell lung cancer
Yafei Shi, Di Qian, Yanhui Li, Wei Chen, Mingming Bo, Mingyu Zhang, Jianglei Shi, Bei Jia, Yuanyuan Dai, Guohui Li
Translational Cancer Research  
2023;
12
(4)
:928-938
.
Characteristics and survival analysis of breast cancer survivors with metachronous double primary cancers: a retrospective cohort study
Ying Song, Jinlu Wang, Xiuli Wang, Rui Li, Xingjian Niu, Yue Yang, Xudong Yang, Lei Yin, Yiran Wang, Han Zhang, Ruixue Shui, Cuiying Zhang, Jing An
Translational Cancer Research  
2023;
12
(4)
:939-948
.
Integrated analysis of coexpression and a tumor-specific ceRNA network revealed a potential prognostic biomarker in breast cancer
Mengmeng Zheng, Linfeng Wu, Rongyao Xiao, Yuying Zhou, Jiaohao Cai, Weike Chen, Chao Chen, Kaiting Sun, Shurong Shen
Translational Cancer Research  
2023;
12
(4)
:949-964
.
Development and validation of a predictive nomogram for the specific mortality risk of luminal B breast cancer patients: a competing risk model based on real populations
Huimin Zhao, Haoxiang Yan, Lianju Chen, Yafei Li
Translational Cancer Research  
2023;
12
(4)
:965-979
.
Correlation of gene expression profiles to identify pancreatic cancer cell lines that best model primary human tumors
Yan Hu, Peng Gao, Gaoqi Xu, Jiao Sun, Wenxiu Xin, Sisi Kong, Haiying Ding, Junfeng Zhu, Luo Fang
Translational Cancer Research  
2023;
12
(4)
:980-991
.
N6-methyladenosine reader IGF2BP3 as a prognostic Biomarker contribute to malignant progression of glioma
Xin Zheng, Shenggang Li, Ju Yu, Chungang Dai, Suji Yan, Gang Chen, Chao Sun
Translational Cancer Research  
2023;
12
(4)
:992-1005
.
Network pharmacology- and molecular docking-based investigation of the therapeutic potential and mechanism of daucosterol against multiple myeloma
Junquan Zeng, Quanying Luo, Xiaoping Wang, Wenguo Xie, Si Dong, Huan Fu, Yujing Wei, Tingting Liu
Translational Cancer Research  
2023;
12
(4)
:1006-1020
.
Identification of GINS1 as a potential prognostic biomarker for sarcoma using bioinformatic analysis
Huanhuan Zhao, Xiaoxia He, Zhanbei Ma
Translational Cancer Research  
2023;
12
(4)
:1021-1032
.

Case Report

A case report of primary angiosarcoma of the breast
Junying Huang, Daheng Xian, Yidong Zhou, Feng Mao, Yan Lin, Songjie Shen, Xiaohui Zhang, Qiang Sun
Translational Cancer Research  
2023;
12
(4)
:1033-1040
.
Effectiveness of tislelizumab when combined with etoposide and carboplatin in patients with SMARCA4-deficient undifferentiated thoracic tumor: a case report
Pan Yang, Fu Xiong, Yong Lin, Peiqiang Liang, Chunlan Tang
Translational Cancer Research  
2023;
12
(4)
:1041-1048
.
Large rectal diverticulum in the setting of pelvic organ prolapse treated with robotic ventral mesh rectopexy: a case report
Leonardo Bustamante-Lopez, David Habib, Charli Pogany, George Nassif, Matthew Albert, Mark K. Soliman, John R. T. Monson, Teresa DeBeche-Adams
Translational Cancer Research  
2023;
12
(4)
:1049-1053
.
A case report of T-LGL leukemia-associated pure red cell aplasia harboring STAT3, TNFAIP3, and KMT2D mutation
Meixiao Shen
Translational Cancer Research  
2023;
12
(4)
:1054-1059
.
Primary pulmonary artery chondrosarcoma: case report
Yucong Zhang, Gang Xu
Translational Cancer Research  
2023;
12
(4)
:1060-1066
.